Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
18 April 2024 | Story Andre Damons | Photo Charl Devenish
Dr Osayande Evbuomwan
Dr Osayande Evbuomwan, Senior Lecturer and Medical Specialist in the Department of Nuclear Medicine at the University of the Free State (UFS), received the first clinical PhD in nuclear medicine completed at the UFS at the April graduation ceremonies.

Dr Osayande Evbuomwan, Senior Lecturer and Medical Specialist in the Department of Nuclear Medicine, Faculty of Health Sciences, at the University of the Free State (UFS), graduated with the first clinical PhD in nuclear medicine completed at the UFS.

He graduated on Thursday (18 April 2024) at the university’s autumn graduation ceremonies when the Faculty of Health Sciences conferred degrees on its graduation class of 2024.

Dr Evbuomwan, the man behind his department using Lutetium 177 PSMA (Lu-177 PSMA) therapy and now Actinium 225 PSMA therapy to treatment metastatic castrate resistant prostate cancer (MCRPC) – an advanced stage prostate cancer, said his PhD is about using a special radiopharmaceutical called Technetium 99m ECDG to detect active disease in the joints of patients with rheumatoid arthritis (RA).

More opportunities for similar degrees

This research has won him the Society of Nuclear Medicine and Molecular Imaging (SNMMI) International Best Abstract Award for South Africa during last year’s SNMMI 2023 Annual Meeting in the US.

“I am very grateful, and at the same time, proud about this achievement (his PhD). This qualification will definitely give more opportunities for further similar degrees at the department. So yes, I feel very happy and fulfilled.

“Rheumatoid arthritis is a debilitating disease with associated morbidity that can lead to serious joint deformity and destruction. The need for an investigation with a very high diagnostic accuracy in detecting active disease is needed, especially in the detection of subclinical disease. Few prior studies in the literature had shown promising results with Tc 99m ECDG imaging in this regard. So, we decided to conduct a proper prospective study to test this hypothesis,” says Dr Evbuomwan.

This research, he explains, was also aimed at finding out if the new nuclear medicine radiopharmaceutical for the identification of active disease in patients with rheumatoid arthritis can also offer prognostic information. This aspect of the study concluded that this particular radiopharmaceutical (Tc – 99m ECDG) is highly sensitive in identifying synovitis (inflammation of the membrane that protects joints) and is capable of offering prognostic information in patients with rheumatoid arthritis.

This was the first prospective study to assess the prognostic value of this radiopharmaceutical in patients with rheumatoid arthritis, Dr Evbuomwan says.

Researching theranostics in the future

According to him, he had a smooth journey to completing his PhD – something he contributes to support from the fantastic team of three supervisors, the assistant who prepared the radiopharmaceutical, the rheumatology department, the radiographers and nurses at the Department of Nuclear Medicine, and most importantly, his wife and two daughters.

His passion for research, growth and the practice of nuclear medicine were his major motivators on this journey.

Dr Evbuomwan is currently looking at the possibility of starting research on theranostics. The only stumbling block for now, he says, is that the department still does not have a PET/CT camera, as this is very vital in today’s nuclear medicine practice. However, together with the Free State Department of Health, they are working hard to secure one.

“I now want to focus on nuclear medicine therapy and its promotion. This includes both imaging and treatment (theranostics) of certain cancers, most especially prostate cancer, neuroendocrine neoplasms, thyroid cancers and the neuroectodermal tumours. I also want to focus on being involved with the training of more registrars at the department of nuclear medicine and increasing the awareness of nuclear medicine amongst colleagues in the Free State,” says Dr Evbuomwan about his future plans. 

News Archive

Multilingualism and exclusion to be discussed
2007-11-27

 
 Some of the UFS staff who will be attending the colloquium on multilinguisim and exclusion in Antwerp, Belgium are, from the left, front: Prof. Theo du Plessis and Ms Susan Lombaard; back: Prof. Johan Lubbe and Mr Roelof Geyser. All are from the Unit for Language Management.
 
Multilingualism and exclusion to be discussed

Five members of the University of the Free State’s (UFS) Unit for Language Management will be taking part in an international colloquium at the University of Antwerp in Belgium on the theme: “Multilingualism and exclusion – perspectives on language and society” this week.

“During this week’s colloquium, approximately twenty South African and Flemish colleagues will reflect on the complex relationships within multilingual communities, where a variety of factors can contribute to the inclusion or exclusion of individuals or communities. Some of the papers will focus on policy measures (“from above”) with regard to the relative position of languages in a particular state, and the impact of these policy measures on the lives of language users. Others will investigate perceptions and “appropriation” (“from below”) by the same language user. In view of the multiple points of departure, the colloquium should contribute towards a better understanding of the dynamics within multilingual communities,” said Prof. Theo du Plessis, Director of the Unit for Language Management at the UFS.

“To give expression to the theme of multilingualism and exclusion, lectures will be presented in three languages, namely Afrikaans, English and Dutch. Several postgraduate students (from South Africa and Flanders) will also have an opportunity to report on investigations they are conducting within the framework of their master’s degree and doctoral studies,” said Prof. Du Plessis.

The colloquium is a follow-up of an international symposium held at the UFS during April 2006 in which a considerable number of outstanding scholars from various countries participated.

According to Prof. Du Plessis, the proceedings of the symposium held last year will be released in book form as part of the unit’s publication series “Studies in Language Policy in South Africa”, published by Van Schaik Publishers.

This sixth issue in the series entitled: “Multilingualism and Exclusion. Policy, Practice, Prospects” will be released tonight (26 November 2007) by the Permanent Deputy of the Province of Antwerp at a prestigious event during the colloquium. The issue was edited by Prof. Du Plessis, Prof. Pol Cuvelier (University of Antwerp), Dr Michael Meeuwis (University of Ghent) and Ms Lut Teck (Institute for Higher Education and the Arts in Brussels).

The UFS will be represented by Prof. Du Plessis, Prof. Johan Lubbe, Ms Susan Lombaard and Mr Roelof Geyser of the Unit for Language Management, as well as Prof. Jackie Naudé of the Department of Afro-Asiatic Studies, Sign Language and Language Practice. Representatives from the universities of Pretoria, Johannesburg, North West and the Monash University in Johannesburg will also be participating in the colloquium.

Media Release
Issued by: Lacea Loader
Assistant Director: Media Liaison
Tel: 051 401 2584
Cell: 083 645 2454
E-mail: loaderl.stg@ufs.ac.za
26 November 2007

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept